糖尿病视网膜病变临床研究临床试验中失访参与者的特征
该回顾性队列研究分析了糖尿病视网膜病变临床研究视网膜网络临床试验中符合纳入标准的参与者,描述了队列的种族/民族构成和健康状态/疾病严重程度,并比较了未完成试验(失访)的比例。8项试验共3492名参与者纳入分析,失访者更可能较年轻、西班牙裔或黑人、患1型糖尿病、基线最佳矫正视力更差、血红蛋白A1c更高、血压更高以及患有增殖性糖尿病视网膜病变(糖尿病视网膜病变严重程度评分>66)。
要点
- 8项糖尿病视网膜病变临床研究视网膜网络试验共3492名参与者纳入分析。
- 失访者更可能较年轻、西班牙裔或黑人、患1型糖尿病。
- 失访者基线最佳矫正视力更差、血红蛋白A1c更高、血压更高、患有增殖性糖尿病视网膜病变(糖尿病视网膜病变严重程度评分>66)。
核心结论
- 糖尿病视网膜病变临床研究临床试验中失访的参与者往往较年轻、为西班牙裔或黑人,并且糖尿病和高血压更严重。
- 该研究强调了确保在整个研究期间维持代表性人群的重要性。
研究设计与样本
- 回顾性队列研究,纳入符合入选标准的糖尿病视网膜病变临床研究视网膜网络临床试验参与者,共8项试验3492名参与者。
主要发现
- 失访者更可能较年轻、西班牙裔或黑人、患1型糖尿病、基线最佳矫正视力更差、血红蛋白A1c更高、血压更高以及患有增殖性糖尿病视网膜病变(糖尿病视网膜病变严重程度评分>66)。
关键数值与推荐
- 增殖性糖尿病视网膜病变定义为糖尿病视网膜病变严重程度评分>66。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our study describes the racial/ethnic composition and the broad health status/severity of disease of the cohorts of Diabetic Retinopathy Clinical Research clinical trials and compares the rates of noncompletion of the trial with the first data report (lost to follow-up). METHODS: This study is a retrospective cohort study of participants in Diabetic Retinopathy Clinical Research Retina Network clinical trials who met our inclusion criteria. The primary outcome was the lost to follow-up rates and their associated risk factors. RESULTS: Eight clinical trials with 3,492 participants met our inclusion criteria. Participants who were lost to follow-up were more likely to be younger, Hispanic or Black, had Type 1 diabetes mellitus, had worse baseline best-corrected visual acuity, had higher hemoglobin A1c, had higher blood pressure, and had proliferative diabetic retinopathy (PDR) (Diabetic Retinopathy Severity Score >66). CONCLUSION: Participants who were lost to follow-up during Diabetic Retinopathy Clinical Research clinical trials tended to be younger, Hispanic or Black, and had worse diabetes and hypertension. This study highlights the importance of ensuring that a representative population is maintained through the end of the study period.
引用
- Bowe T, Mahmoudzadeh R, Soares RR, et al. CHARACTERISTICS OF PARTICIPANTS IN DIABETIC RETINOPATHY CLINICAL RESEARCH CLINICAL TRIALS WHO WERE LOST TO FOLLOW-UP. Retina. 2024. PMID: 37603443. doi:10.1097/IAE.0000000000003911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。